Funded Tech Companies
Ruxton Pharmaceuticals
Wondering who provided funding to Ruxton Pharmaceuticals? New Enterprise Associates and Domain Associates joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Ruxton Pharmaceuticals
Company Status
Out of Business
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2330 W. Joppa Road 355
Lutherville, MD 21093
USA
Lutherville, MD 21093
USA
Phone
Website
Email Address
Company Background Information
Overview
Ruxton Pharmaceuticals is an emerging pharmaceutical company that has been formed to discover, develop and market drugs for the treatment of neurodegenerative diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/10/2008
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Chipkin
Chief Scientific Officer
Rita Sattler
Founder
Jeffrey Rothstein
Company Investors
- New Enterprise Associates (James Barrett)
- Domain Associates (Nicole Vitullo)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs